肿瘤氧合影像学生物标志物:动态磁敏感对比成像预测成人型弥漫性胶质瘤IDH突变状态
本回顾性研究纳入296例成人型弥漫性胶质瘤患者(237例IDH野生型,59例IDH突变型),评估DSC成像获得的肿瘤氧合参数对IDH突变状态的预测价值。结果显示,在全组患者中,CMRO2和OEF第10百分位数可独立预测IDH突变,联合年龄、额叶位置、强化肿瘤存在及nCBV第90百分位数,AUC为0.92;在无强化肿瘤亚组中,CMRO2第10百分位数可独立预测IDH突变,联合年龄和ADC第10百分位数,AUC为0.94。
要点
- 全组中CMRO2和OEF第10百分位数越低越提示IDH突变,联合临床及影像指标AUC达0.92。
- 无强化肿瘤亚组中CMRO2第10百分位数越低越提示IDH突变,联合年龄和ADC第10百分位数AUC达0.94。
- DSC灌注成像衍生的肿瘤氧合参数可能辅助无创预测成人型弥漫性胶质瘤IDH突变。
核心结论
- 肿瘤氧合参数(包括CMRO2和OEF)可能独立于已知临床和定量影像数据预测IDH突变;全肿瘤中较低的CMRO2和OEF第10百分位数预测IDH突变,无强化肿瘤患者中较低的CMRO2第10百分位数预测IDH突变。
研究设计与样本
- 回顾性研究,纳入296例成人型弥漫性胶质瘤患者(237例IDH野生型,59例IDH突变型),从自动分割的肿瘤掩膜获取DSC成像的nCBV、CMRO2、毛细血管通过时间异质性和OEF值以及DWI的ADC值,在全组患者及46例(15.6%)无强化肿瘤亚组中进行逻辑回归分析。
诊断标准与关键数值
- 全组患者中,CMRO2第10百分位数(OR=0.64,p<0.001)和OEF第10百分位数(OR=0.32,p<0.001)独立预测IDH突变,联合年龄、额叶位置、强化肿瘤存在及nCBV第90百分位数,AUC为0.92(95%CI 0.88-0.95)。
- 无强化肿瘤亚组中,CMRO2第10百分位数(OR=0.58,p=0.044)独立预测IDH突变,联合年龄和ADC第10百分位数,AUC为0.94(95%CI 0.83-0.99)。
临床应用与阅片要点
- DSC灌注成像衍生的肿瘤氧合参数可能辅助无创预测成人型弥漫性胶质瘤IDH突变状态。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the role of tumor oxygenation imaging parameters in predicting the isocitrate dehydrogenase (IDH) mutation status in adult-type diffuse gliomas.
METHODS: This retrospective study included 296 patients with adult-type diffuse glioma (237 IDH-wildtype, 59 IDH-mutant). The normalized cerebral blood volume (nCBV), cerebral metabolic rate of oxygen values (CMRO2), capillary transit time heterogeneity, and oxygen extraction fraction (OEF) values from dynamic susceptibility contrast (DSC) imaging and ADC values from DWI were obtained from autosegmented tumor masks. Logistic analyses were performed in entire patients and in a subgroup of 46 patients (15.6%) without CE tumors.
RESULTS: In entire patients, 10th percentile of CMRO2 (odds ratio [OR] = 0.64, p < 0.001) and 10th percentile of OEF (OR = 0.32, p < 0.001) independently predicted IDH mutation, along with age, frontal location, presence of CE tumor, and 90th percentile of nCBV, with an area under the curve (AUC) of 0.92 (95% confidence interval [CI] 0.88-0.95). In the subgroup of patients without CE tumors, 10th percentile of CMRO2 (OR = 0.58, p = 0.044) was an independent predictor for IDH mutation, along with age, and 10th percentile of ADC with an AUC of 0.94 (95% CI 0.83-0.99).
CONCLUSION: Tumor oxygenation parameters, including CMRO2 and OEF, may predict IDH mutation independently of previously known clinical and quantitative imaging data. Lower 10th percentile of CMRO2 and OEF predicts IDH mutation in entire tumors, while lower 10th percentile of CMRO2 predicts IDH mutation in patients without CE tumors.
KEY POINTS: Question The role of tumor oxygenation imaging parameters for predicting the IDH mutation status in adult-type diffuse gliomas is unknown. Findings Lower cerebral metabolic rate of oxygen values (CMRO2) and oxygen extraction fraction (OEF) predicted IDH mutation in entire tumors, while lower CMRO2 predicted IDH mutation in patients without enhancing tumors. Clinical relevance Tumor oxygenation parameters derived from dynamic susceptibility contrast (DSC) perfusion imaging may assist noninvasive prediction of IDH mutation in adult-type diffuse gliomas.
引用
- Park YW, Han K, Jang G, et al. Tumor oxygenation imaging biomarkers using dynamic susceptibility contrast imaging for prediction of IDH mutation status in adult-type diffuse gliomas. Eur Radiol. 2025. PMID: 40411552. doi:10.1007/s00330-025-11704-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。